SecBot SecBot
144 ·Filed Oct 30, 2026

REGN

REGENERON PHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed17d 7h ago SEC0001950047-26-010507
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine Form 144 by a director exercising and selling option shares. The small size relative to market cap and total shares outstanding suggests no material insider signal. Monitor for any subsequent Form 4 filings to confirm execution.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$961.26
T+0 close · Oct 30, 2026 · via day close
Latest settled
−4.30%
T+5 · $919.96 · next T+20 in 14d
Vs SPY
−4.37%
α at T+5
Latest observation
−0.14%
T+9 · FF3 residual α
  1. T+0 · Nov 2 $961.26entry
  2. T+1 · 14d ago +1.26%α +0.96% · $973.36
  3. T+5 · 8d ago −4.30%α −4.37% · $919.96
  4. T+10 · todayOpen
  5. T+20 · in 14d Pending
  6. T+60 · in 2mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Michael S. Brown filed a Form 144 notice of intent to sell 1,929 shares of Regeneron common stock, with an approximate market value of $1.58 million based on the filing date. The shares were acquired through stock option exercises, and the sale is planned for execution on October 30, 2026.

Key Facts

  • Reporting person: Michael S. Brown, a Director of Regeneron Pharmaceuticals, Inc.
  • Proposed sale of 1,929 shares of common stock.
  • Estimated aggregate market value: $1,579,407.33.
  • Shares acquired via exercise of stock options on October 30, 2026.
  • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services.
  • Sale intended to be executed on October 30, 2026.
  • Total shares outstanding (approximate): 103,447,859.
  • Proposed sale represents approximately 0.002% of shares outstanding.

Financial Impact

Proposed sale of 1,929 shares valued at approximately $1.58 million, representing about 0.002% of outstanding shares.

dilution

Risk Factors

  • Form 144 is an intent to sell; the sale may not be executed.
  • Insider selling, even small, can be perceived negatively by some market participants.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
70% bullish (37 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010507
Document: 0001950047-26-010507-index.html0001950047-26-010507
Document: 0001950047-26-010507.txt0001950047-26-010507

Track record

53 reports on REGN

Performance horizon

11 of 17 bullish or bearish reports moved the stock their way by T+20. Best: +31.76% at T+20 after the Oct 6, 2026 report. 17 of 21 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $951.23 Now $952.40 +0.12% settles Dec 16
  2. Nov 16, 2026today 144 Neutral 2/10 Entry $948.00 Now $952.40 +0.46% settles Dec 16
  3. Nov 12, 20264d ago Press Release Bullish 5/10 Entry $955.47 Now $952.40 −0.32% settles Dec 14
  4. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $904.35 Now $952.40 +5.31% settles Dec 7
  5. Nov 5, 202611d ago Insider Cluster Neutral 3/10 Entry $904.35 Now $952.40 +5.31% settles Dec 7
  6. Nov 4, 202612d ago 144 Neutral 1/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
  7. Nov 4, 202612d ago 144 Neutral 2/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
  8. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
  9. Nov 3, 202613d ago 144 Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
  10. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
Showing 10 of 53

US Market Status

Market Closed · Opens Wed (10h 34m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 30, 2026